Cargando…
Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
BACKGROUND: Ovarian cancer is the most leading cause of death and the third most common gynecologic malignancy in women. Traditional chemotherapy has inevitable drawbacks of nonspecific tumor targeting, high toxicity, and poor therapeutic efficiency. In order to overcome such shortcomings, we prepar...
Autores principales: | Yao, Shu, Li, Li, Su, Xuan-tao, Wang, Kai, Lu, Zai-jun, Yuan, Cun-zhong, Feng, Jin-bo, Yan, Shi, Kong, Bei-hua, Song, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389131/ https://www.ncbi.nlm.nih.gov/pubmed/29478415 http://dx.doi.org/10.1186/s13046-018-0700-z |
Ejemplares similares
-
Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo
por: Ma, Peilin, et al.
Publicado: (2023) -
Characterization of an Amphiphilic Phosphonated Calixarene Carrier Loaded With Carboplatin and Paclitaxel: A Preliminary Study to Treat Colon Cancer in vitro and in vivo
por: Li, Meiying, et al.
Publicado: (2019) -
Hypocrellin B‐loaded, folate‐conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo
por: Li, Jie, et al.
Publicado: (2018) -
Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo
por: Wei, Yuxun, et al.
Publicado: (2023) -
Advanced Nano-Carriers for Anti-Tumor Drug Loading
por: Xiang, Jia, et al.
Publicado: (2021)